Trib+Health is joining with respected books authority Kirkus Reviews to bring you select reviews of books of note in the field of health care. For more book reviews and recommendations, visit Kirkus.com.
by Jon Palfreman
Prospects for better treatments for Parkinson’s disease are the hope that lies at the end of this well-researched history and overview of the current state of research. Palfreman brings his skill as a science writer and a deep personal commitment to an initially dark narrative. A generation ago, L-dopa was the breakthrough drug that would supply dopamine … to neurons in movement control centers. Thus it would stop the tremors, falls, and other signs of Parkinson’s—except when it didn’t … Fortunately, there are promising developments on the horizon … Palfreman reminds patients that exercise and a positive attitude help, and he urges them to participate in clinical trials and take to task drug companies reluctant to initiate huge trials for what they dismiss as a non–life-threatening disease.
For the full review, visit kirkus.com